埃塞俄比亚西北地区患者对抗逆转录病毒疗法服务的偏好:一个离散选择实验

Yihalem Abebe Belay1,2, Mezgebu Yitayal2, Asmamaw Atnafu2

  • 1Department of Public Health, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.

MDM policy & practice
|September 3, 2024
PubMed
概括

患者更喜欢在医疗机构接受抗逆转录病毒疗法 (ART) 补充,访问次数更少,成本更低. 了解这些偏好是以患者为中心的HIV护理的关键.